Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Aclarion, Inc.

ACON · Nasdaq · CIK 0001635077 · Healthcare · Health Information Services

INSIDER SIGNAL

71.2 / 100

7 buyers · 10 purchase transaction lines · $176.6K gross purchase

WHY THIS SIGNAL?

Buyer breadthStrong
Purchase sizeLow
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+35.0 / 35
Purchase size+9.6 / 25
Role+13.0 / 20
Recency+3.6 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent
  • ✓ Cluster breadth is broad · 4+ insiders

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Ness BrentChief Executive Officer
●○●
Wesemann WilliamDirector
●○●
Neal David KDirector
●○●
Bond RyanChief Strategy Officer
○●
Gould Gregory AChief Financial Officer
○●
Breidbart ScottDirector
●○
● Purchase▼ Sale○ Other

Showing the six most active owners; 4 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS7
PURCHASE CONCENTRATION28%Largest buyer: Bond Ryan · $50.1K
CLUSTER BUYING · 15D6 insidersPeak activity: 2026-08-13–2026-08-17

Roles in the peak window: CFO, Chief Executive Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

71.2 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 71.5
  2. 71.5
  3. 71.4
  4. 71.3
  5. 71.2

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

11Purchases
0Sales
9Other Form 4 lines
20SEC filings · 365 days
BUYING10 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-7.9%
3M
-13.0%
6M
-27.6%
12M
-73.7%

Volatility & liquidity

Volatility
179.5%
Beta
—
Avg daily value
USD 121,947

Valuation

Market cap
USD 6.7M
P/E
—

Fundamentals

Profit margin
—
ROE
-56.4%
Industry
Health Information Services

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-04 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
48,934
Previous report
76,007
Avg daily volume
62,470
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-17Williams Amanda MPurchase (P)Common Stock5,857USD 2.73USD 15,990SEC filing ↗
2026-08-14Gould Gregory APurchase (P)Common Stock10,000USD 2.45USD 24,500SEC filing ↗
2026-08-13Wesemann WilliamPurchase (P)Common Stock2,150USD 2.34USD 5,031SEC filing ↗
2026-08-13Ness BrentPurchase (P)Common Stock5,234USD 2.31USD 12,091SEC filing ↗
2026-08-13Neal David KPurchase (P)Common Stock7,500USD 2.40USD 18,000SEC filing ↗
2026-08-13Bond RyanPurchase (P)Common Stock21,122USD 2.37USD 50,059SEC filing ↗
2026-05-12Breidbart ScottPurchase (P)Common Stock5,664USD 3.18USD 18,012SEC filing ↗
2026-05-11Neal David KPurchase (P)Common Stock2,500USD 3.10USD 7,750SEC filing ↗
2026-05-11Ness BrentPurchase (P)Common Stock6,289USD 3.18USD 19,999SEC filing ↗
2026-05-06Wesemann WilliamPurchase (P)Common Stock1,562USD 3.30USD 5,155SEC filing ↗
2025-11-26Ness BrentPurchase (P)Common Stock10USD 6.20USD 62SEC filing ↗
2023-02-16Thramann Jeffrey JohnPurchase (P)Series A Preferred Stock1USD 1,000.00USD 1,000SEC filing ↗
2022-12-29Ness BrentPurchase (P)Common Stock16,211USD 0.54USD 8,807SEC filing ↗
2022-12-29Lorbiecki John PaulPurchase (P)Common Stock22,404USD 0.45USD 10,000SEC filing ↗
2022-12-28Ness BrentPurchase (P)Common Stock2,289USD 0.42USD 961SEC filing ↗

Form 4 evidence

20 transaction lines in the latest 365-day window; 34 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-17Williams Amanda MPurchase (P)Common Stock5,857USD 2.73USD 15,990SEC filing ↗
2026-08-14Gould Gregory APurchase (P)Common Stock10,000USD 2.45USD 24,500SEC filing ↗
2026-08-13Wesemann WilliamPurchase (P)Common Stock2,150USD 2.34USD 5,031SEC filing ↗
Show recent Form 4 evidence (20 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-17Williams Amanda MPurchase (P)Common Stock5,857USD 2.73USD 15,990SEC filing ↗
2026-08-14Gould Gregory APurchase (P)Common Stock10,000USD 2.45USD 24,500SEC filing ↗
2026-08-13Wesemann WilliamPurchase (P)Common Stock2,150USD 2.34USD 5,031SEC filing ↗
2026-08-13Ness BrentPurchase (P)Common Stock5,234USD 2.31USD 12,091SEC filing ↗
2026-08-13Neal David KPurchase (P)Common Stock7,500USD 2.40USD 18,000SEC filing ↗
2026-08-13Bond RyanPurchase (P)Common Stock21,122USD 2.37USD 50,059SEC filing ↗
2026-06-11Wesemann WilliamAward / grant (A)Common Stock20,000USD 0.00USD 0SEC filing ↗
2026-06-11Thramann Jeffrey JohnAward / grant (A)Common Stock100,000USD 0.00USD 0SEC filing ↗
2026-06-11Sequira Amanda MaeAward / grant (A)Common Stock20,000USD 0.00USD 0SEC filing ↗
2026-06-11Ness BrentAward / grant (A)Common Stock100,000USD 0.00USD 0SEC filing ↗
2026-06-11Neal David KAward / grant (A)Common Stock20,000USD 0.00USD 0SEC filing ↗
2026-06-11Gould Gregory AAward / grant (A)Common Stock50,000USD 0.00USD 0SEC filing ↗
2026-06-11Deitsch StephenAward / grant (A)Common Stock20,000USD 0.00USD 0SEC filing ↗
2026-06-11Breidbart ScottAward / grant (A)Common Stock20,000USD 0.00USD 0SEC filing ↗
2026-06-11Bond RyanAward / grant (A)Common Stock55,000USD 0.00USD 0SEC filing ↗
2026-05-12Breidbart ScottPurchase (P)Common Stock5,664USD 3.18USD 18,012SEC filing ↗
2026-05-11Neal David KPurchase (P)Common Stock2,500USD 3.10USD 7,750SEC filing ↗
2026-05-11Ness BrentPurchase (P)Common Stock6,289USD 3.18USD 19,999SEC filing ↗
2026-05-06Wesemann WilliamPurchase (P)Common Stock1,562USD 3.30USD 5,155SEC filing ↗
2025-11-26Ness BrentPurchase (P)Common Stock10USD 6.20USD 62SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerACON
CIK0001635077
SectorHealthcare
IndustryHealth Information Services Yahoo Finance
SEC SIC8071 Services-Medical Laboratories
ExchangeNasdaq

Data coverage

Local Form 4 history34 transaction lines from 2022-04-21 to 2026-08-17
21 P purchase lines · 0 S sale lines · 13 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.